Virtus Lifesci Biotech Etf Performance
| BBC Etf | USD 40.87 1.99 5.12% |
The entity has a beta of 0.76, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Virtus LifeSci's returns are expected to increase less than the market. However, during the bear market, the loss of holding Virtus LifeSci is expected to be smaller as well.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental drivers, Virtus LifeSci exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Biotech ETF Hits New 52-Week High - Zacks Investment Research | 12/01/2025 |
2 | Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com | 12/18/2025 |
Virtus LifeSci Relative Risk vs. Return Landscape
If you would invest 3,033 in Virtus LifeSci Biotech on November 10, 2025 and sell it today you would earn a total of 1,054 from holding Virtus LifeSci Biotech or generate 34.75% return on investment over 90 days. Virtus LifeSci Biotech is generating 0.5136% of daily returns assuming volatility of 2.5355% on return distribution over 90 days investment horizon. In other words, 22% of etfs are less volatile than Virtus, and above 90% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
3 y Volatility 36.4 | 200 Day MA 27.5505 | 1 y Volatility 39.29 | 50 Day MA 39.589 | Inception Date 2014-12-16 |
Virtus LifeSci Target Price Odds to finish over Current Price
The tendency of Virtus Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 40.87 | 90 days | 40.87 | about 19.74 |
Based on a normal probability distribution, the odds of Virtus LifeSci to move above the current price in 90 days from now is about 19.74 (This Virtus LifeSci Biotech probability density function shows the probability of Virtus Etf to fall within a particular range of prices over 90 days) .
Virtus LifeSci Price Density |
| Price |
Predictive Modules for Virtus LifeSci
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Virtus LifeSci Biotech. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Virtus LifeSci Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Virtus LifeSci is not an exception. The market had few large corrections towards the Virtus LifeSci's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Virtus LifeSci Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Virtus LifeSci within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | 0.76 | |
σ | Overall volatility | 3.89 | |
Ir | Information ratio | 0.15 |
Virtus LifeSci Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Virtus LifeSci for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Virtus LifeSci Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The fund generated five year return of -4.0% | |
| Virtus LifeSci Biotech holds 98.9% of its assets under management (AUM) in equities |
Virtus LifeSci Fundamentals Growth
Virtus Etf prices reflect investors' perceptions of the future prospects and financial health of Virtus LifeSci, and Virtus LifeSci fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Virtus Etf performance.
| Price To Earning | 39.87 X | |||
| Price To Book | 1.75 X | |||
| Price To Sales | 1.99 X | |||
| Total Asset | 18.12 M | |||
About Virtus LifeSci Performance
By analyzing Virtus LifeSci's fundamental ratios, stakeholders can gain valuable insights into Virtus LifeSci's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Virtus LifeSci has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Virtus LifeSci has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.| The fund generated five year return of -4.0% | |
| Virtus LifeSci Biotech holds 98.9% of its assets under management (AUM) in equities |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Virtus LifeSci Biotech's market price often diverges from its book value, the accounting figure shown on Virtus's balance sheet. Smart investors calculate Virtus LifeSci's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Virtus LifeSci's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Virtus LifeSci's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Virtus LifeSci should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.